COG2 and coronary artery disorder: The Framingham Heart Study identified cholesterol as a risk factor associated with coronary artery disease (CAD) in 1961 and since then, growing clinical, epidemiologic, and randomized trial evidence has firmly established LDL-C as a causal and highly modifiable risk factor in the development and pathogenesis of ASCVD [12,13].